Merck to support SaudiVax in becoming first developer and manufacturer of Saudi halal vaccines

RIYADH, Saudi Arabia, Nov. 3, 2021 – Merck, a leading science and technology company, today announced that it will support SaudiVax Ltd., based in the Kingdom of Saudi Arabia, to design a best-in-class, multi-modality manufacturing facility to localize manufacturing of biologics and vaccines for the MENA region. 

SaudiVax is positioned to become the first developer and manufacturer of Halal vaccines and biotherapeutics in Saudi Arabia, leveraging Merck's integrated Contract Development Manufacturing Services (CDMO), innovative product offerings and single-use technologies.

"With more than 30 years of experience designing, building and operating our own global CDMO network, we are pleased to support SaudiVax in fulfilling its mission to localize the development and manufacturing of vaccines and therapeutics in Saudi Arabia," said Sébastien Ribault, Head of End-to-End Contract Development Manufacturing Organization (CDMO) Services, Life Science business sector at Merck. "This partnership brings together our shared commitment to expand access to life-saving and life-enhancing therapies."